**Core Concept**
Enterohepatic circulation refers to the process by which a compound is secreted into the bile and then reabsorbed from the intestine, allowing it to recirculate back to the liver. This phenomenon is crucial for the pharmacokinetics of certain drugs, including some nonsteroidal anti-inflammatory drugs (NSAIDs).

**Why the Correct Answer is Right**
One notable NSAID that undergoes enterohepatic circulation is **diclofenac**. This process allows diclofenac to have a longer half-life and increased bioavailability. Diclofenac is primarily metabolized by the liver, but its enterohepatic recirculation contributes to its prolonged action and reduced clearance.

**Why Each Wrong Option is Incorrect**
* **Option A:** Ibuprofen does not undergo significant enterohepatic circulation. Its pharmacokinetics are primarily determined by renal excretion and first-pass metabolism.
* **Option B:** Naproxen has a moderate enterohepatic circulation, but it is not as extensive as diclofenac's.
* **Option C:** Aspirin does not undergo enterohepatic circulation; its main elimination pathways involve renal excretion and hepatic metabolism.

**Clinical Pearl / High-Yield Fact**
Diclofenac's enterohepatic circulation can lead to increased accumulation of its metabolites, particularly in patients with renal impairment or liver disease. This highlights the importance of monitoring patients for potential side effects, especially when using this NSAID in vulnerable populations.

**Correct Answer:** D. Diclofenac.